Analyst Ratings for Caris Life Sciences Inc (CAI)

CAI Rating Summary

CAI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CAI
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $30.58 (+65.6%) * Over Last 12-Mos
Rating Score: 6.1 / 10   Percentile Rank: 65%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/1/2026 Wolfe Research Mike Polark New Coverage Peerperform
(N/A)
N/A
(N/A)
16.72
(18.47)
10.47% Details
4/13/2026 Jefferies Tycho Peterson New Coverage Buy
(N/A)
28.00
(N/A)
19.20
(18.47)
-3.8% Details